Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Merck Climbs on the Emerging Markets Bandwagon

publication date: Nov 11, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Merck wants to be either number one or two in China’s healthcare market within the next five to seven years. Much like all the major multinational pharmas, Merck is de-emphasizing its old business model, based on patented blockbuster drugs for Western markets, and turning to emerging markets for its future growth. The company wants emerging markets to generate one-fourth of all revenue by 2013, up from 18% currently. More details....

Stock Symbol: (NYSE: MRK)



Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners